None of the antidepressants tested (ketamine, clomipramine, trazodone, or fluoxetine) promoted significant changes in fndc5 expression in the hippocampus (Fig. 5B), a brain region also linked to depression (Tsankova et al., 2006). The gene discussed is FNDC5; the disease is depressive symptom measurement.